Pangea's ENLIGHT platform is designed to predict patient response to more than 100 oncology drugs that are designed to treat dozens of types of cancer. ENLIGHT uses a two-layer, transcriptomics-based computational approach to predict the effectiveness of cancer therapies on individual patients in multiple cancer types by identifying clinically relevant genomic interactions. Using a proprietary ENLIGHT Matching Score (EMS), oncologists can identify a treatment’s efficacy potential for each individual patient, regardless of cancer type . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge